Literature DB >> 9882631

Changes in the protein pattern of H1 histones associated with apoptotic DNA fragmentation.

M Kratzmeier1, W Albig, T Meergans, D Doenecke.   

Abstract

Characteristic steps in the course of cellular apoptosis are the induction of chromatin condensation and cleavage of the DNA, leading to the formation of oligomers of nucleosomes. Since the H1 histones represent functional elements that are essential for the generation of highly condensed chromatin structures, we analysed the total cellular H1 histones of five leukaemic and three solid human tumour cell lines, comparing the H1 pattern of exponentially growing cells with that of apoptotic cells. For the induction of apoptosis, cell lines were treated with the water-soluble camptothecin derivative, topotecan (a topoisomerase I inhibitor), or with an apoptosis-inducing monoclonal anti-CD95 (Fas/APO-1) antibody. Total histone H1 proteins were isolated by extraction with 5% perchloric acid and were analysed by means of capillary zone electrophoresis (CZE) separation. The identities of the peaks representing different histone H1 subtypes on CZE electropherograms were confirmed by analysis of preparations (recombinant proteins purified from transformed yeast used as internal standards) mixed with each of the subtypes respectively. The progress of topotecan- or anti-CD95-induced cell death was monitored by flow cytometry analysis and also by agarose electrophoresis of fragmented DNA. During early apoptosis of three of these cell lines, we observed the induction of internucleosomal DNA cleavage and, simultaneously, a typical change in the histone H1 protein pattern, leading to an increase in the relative amounts of histone subtypes H1.4 and H1.5. Upon apoptosis induction, these changes were only observed in correlation with the occurrence of DNA fragmentation, thus possibly reflecting a prerequisite for DNA accessibility and/or endonuclease activity.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9882631      PMCID: PMC1219968     

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  25 in total

1.  Roles of H1 domains in determining higher order chromatin structure and H1 location.

Authors:  J Allan; T Mitchell; N Harborne; L Bohm; C Crane-Robinson
Journal:  J Mol Biol       Date:  1986-02-20       Impact factor: 5.469

Review 2.  Quantification of apoptotic events in pure and heterogeneous populations of cells using the flow cytometer.

Authors:  P J Fraker; L E King; D Lill-Elghanian; W G Telford
Journal:  Methods Cell Biol       Date:  1995       Impact factor: 1.441

3.  Application of high-performance capillary electrophoresis to the analysis of H1 histones.

Authors:  H Lindner; M Wurm; A Dirschlmayer; B Sarg; W Helliger
Journal:  Electrophoresis       Date:  1993 May-Jun       Impact factor: 3.535

Review 4.  Organization and expression of H1 histone and H1 replacement histone genes.

Authors:  D Doenecke; W Albig; H Bouterfa; B Drabent
Journal:  J Cell Biochem       Date:  1994-04       Impact factor: 4.429

5.  Glucocorticoid-induced thymocyte apoptosis is associated with endogenous endonuclease activation.

Authors:  A H Wyllie
Journal:  Nature       Date:  1980-04-10       Impact factor: 49.962

6.  Isolation and characterisation of subfractions of nuclear protein H1 degree.

Authors:  B J Smith; E W Johns
Journal:  FEBS Lett       Date:  1980-01-28       Impact factor: 4.124

7.  The role of cell cycle regulation and apoptosis triggering in determining the sensitivity of leukemic cells to topoisomerase I and II inhibitors.

Authors:  L Dubrez; F Goldwasser; P Genne; Y Pommier; E Solary
Journal:  Leukemia       Date:  1995-06       Impact factor: 11.528

8.  Effect of P-glycoprotein expression on the accumulation and cytotoxicity of topotecan (SK&F 104864), a new camptothecin analogue.

Authors:  C B Hendricks; E K Rowinsky; L B Grochow; R C Donehower; S H Kaufmann
Journal:  Cancer Res       Date:  1992-04-15       Impact factor: 12.701

9.  Effect of buffer composition on the migration order and separation of histone H1 subtypes.

Authors:  H Lindner; W Helliger; B Sarg; C Meraner
Journal:  Electrophoresis       Date:  1995-04       Impact factor: 3.535

10.  Involvement of histone H1 in the organization of the nucleosome and of the salt-dependent superstructures of chromatin.

Authors:  F Thoma; T Koller; A Klug
Journal:  J Cell Biol       Date:  1979-11       Impact factor: 10.539

View more
  5 in total

1.  Polychlorinated biphenyls (PCB-153) and (PCB-77) absorption in human liver (HepG2) and kidney (HK2) cells in vitro: PCB levels and cell death.

Authors:  Somiranjan Ghosh; Supriyo De; Yongqing Chen; Darryl C Sutton; Folahan O Ayorinde; Sisir K Dutta
Journal:  Environ Int       Date:  2010-08-17       Impact factor: 9.621

2.  Histone H1 variants are differentially expressed and incorporated into chromatin during differentiation and reprogramming to pluripotency.

Authors:  Jean-Michel Terme; Borja Sesé; Lluis Millán-Ariño; Regina Mayor; Juan Carlos Izpisúa Belmonte; María José Barrero; Albert Jordan
Journal:  J Biol Chem       Date:  2011-08-18       Impact factor: 5.157

3.  Transcriptome Analysis of Cultured Limbal Epithelial Cells on an Intact Amniotic Membrane following Hypothermic Storage in Optisol-GS.

Authors:  Tor Paaske Utheim; Panagiotis Salvanos; Øygunn Aass Utheim; Sten Ræder; Lara Pasovic; Ole Kristoffer Olstad; Maria Fideliz de la Paz; Amer Sehic
Journal:  J Funct Biomater       Date:  2016-02-18

4.  Depletion of human histone H1 variants uncovers specific roles in gene expression and cell growth.

Authors:  Mónica Sancho; Erika Diani; Miguel Beato; Albert Jordan
Journal:  PLoS Genet       Date:  2008-10-17       Impact factor: 5.917

5.  Mapping of six somatic linker histone H1 variants in human breast cancer cells uncovers specific features of H1.2.

Authors:  Lluís Millán-Ariño; Abul B M M K Islam; Andrea Izquierdo-Bouldstridge; Regina Mayor; Jean-Michel Terme; Neus Luque; Mónica Sancho; Núria López-Bigas; Albert Jordan
Journal:  Nucleic Acids Res       Date:  2014-01-29       Impact factor: 16.971

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.